“As non-clinicians, we were limited in our ability to adequately assess risk and opportunity in our Provider documentation. Prior to 2021 EM changes, we would review bell curve data and perform the audits. Often, the elements were captured with templated notes resulting in providers passing their audits, leaving bell curve variances unresolved. We pondered on how our coding department could support providers beyond just counting the elements in the documentation. Without a clinical perspective, how would we determine the best samples to take into discussions with those providers? When this challenge was presented, they responded beautifully with reveal/MD that provided specific reported diagnoses that could further highlight the presenting conditions with high/low variances as compared to their peers. It was ingenious to create a bell curve specific to billed diagnoses! It has been a game changer in being able to target our review of documentation with the associated diagnosis. We can now easily pull cases based on diagnosis variance to review the presenting problems with possible comorbidities that place patients at a higher or lower risk in comparison to others.”